Levoxyl recalls

Levoxyl products have been recalled 26 times, most recently on 20 Aug 2025. The recalling company is usually Pfizer. The most common reason is potency & assay.

Total recalls26since 2013

Last 12 months0reported

Class I00% of total

Ongoing1latest 20 Aug 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 1Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 26 100%Class III 0 0%

Why levoxyl is recalled

Companies

Pfizer1454%
King Legacy, a wholly owned subsidiary of Pfizer1142%
Cardinal Health14%

Product types

Thyroid Medication26100%

By year

202514%
202114%
201814%
201614%
20132285%

Ongoing levoxyl recalls

1 active

Reported	Class	Recall	Company	Reason	Where
20 Aug 2025Drug	CLASS II	Levoxyl (levothyroxine sodium tablets, USP), 50 mcg recalled by PfizerLevoxyl	Pfizer	Potency & Assay	NY

All levoxyl recalls, newest first

26 total

Reported	Class	Recall	Company	Reason	Where
20 Aug 2025Drug	CLASS II	Levoxyl (levothyroxine sodium tablets, USP), 50 mcg recalled by PfizerLevoxyl	Pfizer	Potency & Assay	NY
2 Jun 2021Drug	CLASS II	Levoxyl Tablets, USD, 150MCG recalled by Cardinal HealthLevoxyl	Cardinal Health	Manufacturing (CGMP) Deviations	FL, GA, SC
26 Dec 2018Drug	CLASS II	Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg recalledLevoxyl	Pfizer	Potency & Assay	Nationwide
30 Nov 2016Drug	CLASS II	Levoxyl(R) (levothyroxine sodium tablets, USP), 200 mcg recalledLevoxyl	Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
29 May 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg recalledLevoxyl	King Legacy, a wholly owned subsidiary of Pfizer	Potency & Assay	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 200 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 175 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 137 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 112 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 50 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 100 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 25 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 125 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 88 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 150 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide
24 Apr 2013Drug	CLASS II	Levoxyl (levothyroxine sodium) tablets, USP 75 mcg recalled by PfizerLevoxyl	Pfizer	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.